Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-20

FDA Approved: NEVIRAPINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental application for Nevirapine, signaling an approved modification to the product's regulatory status. This confir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

SUPPL AP for NEVIRAPINE (NEVIRAPINE)